9C10
AMG 193, a clinical stage MTA-cooperative PRMT5 inhibitor, drives anti-tumor activity preclinically and in patients with MTAP-deleted cancers
This is a non-PDB format compatible entry.
History
Please read more about PDB versioning on our help page.
| Version | Date | Type | |
| 1-0 | 2024-10-02 | Initial release | No files available. |
| 1-1 | 2024-10-09 | Database references, Structure summary | No files available. |
| 1-2 | 2024-11-27 | Refinement description | No files available. |
| 1-3 | 2025-01-22 | Database references |
